Foresight Diagnostics Overview

  • Founded
  • 2020
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series B
  • Investors
  • 5

Foresight Diagnostics General Information

Description

Developer of a novel diagnosis technology designed to detect cancers earlier from a simple blood sample. The company's technology uses the biological features that make each cancer type and each individual person's cancer unique by focusing on the things that differentiate a cancer cell from a healthy cell, enabling healthcare professionals to conduct diagnoses of early smaller tumors and apply personalized and effective cancer treatment strategies for patients.

Contact Information

Website
www.foresight-dx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Primary Office
  • 12635 East Montview Boulevard
  • Suite 224
  • Aurora, CO 80045
  • United States

Foresight Diagnostics Timeline

20212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Foresight Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 01-Dec-2021 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 02-Jun-2021 000.00 000.00 Completed Generating Revenue
To view Foresight Diagnostics’s complete valuation and funding history, request access »

Foresight Diagnostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
To view Foresight Diagnostics’s complete cap table history, request access »

Foresight Diagnostics Executive Team (5)

Name Title Board Seat Contact Info
Jake Chabon Ph.D Co-Founder, CSO, Chief Executive Officer & Board Member
Mukul Agarwal Chief Financial Officer & CBO
Ash Alizadeh MD Co-Founder & Scientific Advisor
Maximilian Diehn MD Co-Founder, Board Member & Advisor
David Kurtz Ph.D Co-Founder & Scientific Advisor
To view Foresight Diagnostics’s complete executive team members history, request access »

Foresight Diagnostics Board Members (5)

Name Representing Role Since
Jake Chabon Ph.D Foresight Diagnostics Co-Founder, CSO, Chief Executive Officer & Board Member 000 0000
Jeffrey Bird Ph.D Bluebird Ventures Board Member 000 0000
Mark Lee MD Self Board Member 000 0000
Maximilian Diehn MD Foresight Diagnostics Co-Founder, Board Member & Advisor 000 0000
Shahram Seyedin-Noor JD Civilization Ventures Board Member 000 0000
To view Foresight Diagnostics’s complete board members history, request access »

Foresight Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Foresight Diagnostics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sand Hill Angels Angel Group Minority 000 0000 000000 0
Bluebird Ventures Venture Capital Minority 000 0000 000000 0
Civilization Ventures Venture Capital Minority 000 0000 000000 0
Pear Venture Capital Minority 000 0000 000000 0
Wilson Sonsini Goodrich & Rosati Investment Fund Other Minority 000 0000 000000 0
To view Foresight Diagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial